Search Results - "Theeuwen, Rosaline"

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study by Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank

“…Abstract Background and Aims Ustekinumab is approved for the treatment of Crohn’s disease [CD]. Systematically registered prospective real-world data are…”
Get full text

Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn’s Disease or Ulcerative Colitis by Kemp, Karen, Dibley, Lesley, Chauhan, Usha, Greveson, Kay, Jäghult, Susanna, Ashton, Katherine, Buckton, Stephanie, Duncan, Julie, Hartmann, Petra, Ipenburg, Nienke, Moortgat, Liesbeth, Theeuwen, Rosaline, Verwey, Marthe, Younge, Lisa, Sturm, Andreas, Bager, Palle

Get full text

Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease by Straatmijer, Tessa, Biemans, Vince B. C., Moes, Dirk Jan A. R., Hoentjen, Frank, ter Heine, Rob, Maljaars, P. W. Jeroen, Theeuwen, Rosaline, Pierik, Marieke, Duijvestein, Marjolijn, van der Meulen-de Jong, Andrea E.

“…Objective It is unknown whether ustekinumab (UST) levels can predict clinical outcomes in Crohn’s disease (CD) patients. We assessed the exposure–response…”
Get full text

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study by Straatmijer, Tessa, Biemans, Vince B.C., Visschedijk, Marijn, Hoentjen, Frank, de Vries, Annemarie, van Bodegraven, Adriaan A., Bodelier, Alexander, de Boer, Nanne K.H., Dijkstra, Gerard, Festen, Noortje, Horjus, Carmen, Jansen, Jeroen M., Jharap, Bindia, Mares, Wout, van Schaik, Fiona D.M., Ponsioen, Cyriel, Romkens, Tessa, Srivastava, Nidhi, van der Voorn, Michael M.P. J.A., West, Rachel, van der Woude, Janneke, Wolvers, Marije D.J., Pierik, Marieke, van der Meulen-de Jong, Andrea E., Duijvestein, Marjolijn, Schlotter, Malena, van Workum, Martine, de Jong, Dirk, van Dop, Willemijn, van der Marel, S., El Ghabzouri, Hayat, Talhaoui, Kamila, Oldenburg, Bas, Boontje, Nynke, Fidder, Herma, Hirdes, Meike, Creemers, Rob H., Hoekstra, J., Smid, Jael, Mujagic, Zlatan, François-Verweij, Marthe, Schakel- van den Berge, Toos, Maljaars, Jeroen, Theeuwen, Rosaline, van den Berg, Denise, Gerretsen, Suzanne, Yocarini, Xenia, D’Haens, Geert, Lowenberg, Mark, Grootjans, Joep, Gecse, Krisztina, Bouma, Gerd, Waaijenberg, Petra, Muskens, Bart

“…Clinicians face difficulty in when and in what order to position biologics and Janus kinase inhibitors in patients with anti-tumor necrosis factor-alpha (TNF)…”
Get full text